Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation

[1]  Z. Ni,et al.  Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[2]  D. Kamp,et al.  Oxidative stress and pulmonary fibrosis. , 2013, Biochimica et biophysica acta.

[3]  Xiaohong Li,et al.  Synergistic promotion of blood vessel regeneration by astragaloside IV and ferulic acid from electrospun fibrous mats. , 2013, Molecular pharmaceutics.

[4]  Niansong Wang,et al.  Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression. , 2013, Cytokine.

[5]  O. Eickelberg,et al.  New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis , 2012, The Lancet.

[6]  C. Barkauskas,et al.  Pulmonary fibrosis: patterns and perpetrators. , 2012, The Journal of clinical investigation.

[7]  N. Todd,et al.  Molecular and cellular mechanisms of pulmonary fibrosis , 2012, Fibrogenesis & tissue repair.

[8]  V. Aidinis,et al.  Modeling pulmonary fibrosis with bleomycin , 2011, Current opinion in pulmonary medicine.

[9]  Thomas A. Wynn,et al.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[10]  R. Homer,et al.  Modern concepts on the role of inflammation in pulmonary fibrosis. , 2011, Archives of pathology & laboratory medicine.

[11]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[12]  T. Oury,et al.  Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. , 2010, Free radical biology & medicine.

[13]  Xian-ji Xie,et al.  Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation. , 2010, Biological & pharmaceutical bulletin.

[14]  Xiaoming Wang,et al.  Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. , 2010, European journal of pharmacology.

[15]  E. White,et al.  Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[16]  N. Zhong,et al.  INHIBITORY EFFECT OF EMODIN ON BLEOMYCIN‐INDUCED PULMONARY FIBROSIS IN MICE , 2009, Clinical and experimental pharmacology & physiology.

[17]  C. Marsh,et al.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. , 2008, Antioxidants & redox signaling.

[18]  Hye-Youn Cho,et al.  Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. , 2008, Antioxidants & redox signaling.

[19]  N. Gedik,et al.  Resveratrol alleviates bleomycin-induced lung injury in rats. , 2007, Pulmonary pharmacology & therapeutics.

[20]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[21]  Florence Lam,et al.  Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. , 2005, World journal of gastroenterology.

[22]  T. Oury,et al.  Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. , 2005, American journal of respiratory and critical care medicine.

[23]  Nicoletta Pellegrini,et al.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[24]  F. Martinez,et al.  Mechanisms of pulmonary fibrosis. , 2004, Annual review of medicine.

[25]  P. Hufnagl,et al.  Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression , 2003, Thrombosis and Haemostasis.

[26]  M. Denis.  Interleukin‐6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL‐6 or direct administration of IL‐6 , 1992, Journal of leukocyte biology.

[27]  D. Lanzo,et al.  Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron. , 1982, Biochemistry.

[28]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.